Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Max Schmidt

Showing results (221-230 of 239) with videos related to

Pageof 24
Sort By:
Annals of Surgery|July 9, 2021
Outcomes in Endoscopic and Operative Transgastric Pancreatic DebridementThomas K Maatman, Sean P McGuire, Katelyn F Flick, et al.
Annals of Surgery|September 3, 2024
Natural History of the Remnant Pancreatic Duct after Pancreatoduodenectomy for Non-Invasive Intraductal Papillary Mucinous Neoplasm: Results from an International ConsortiumRachel C Kim, Giampaolo Perri, Dario M Rocha Castellanos, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alterationMarta Sans, Yihui Chen, Fredrik I Thege, et al.
Diabetes Care|December 12, 2018
Proinsulin Secretion Is a Persistent Feature of Type 1 DiabetesEmily K Sims, Henry T Bahnson, Julius Nyalwidhe, et al.
Diabetes Care|April 24, 2019
Response to Comment on Sims et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258-264Emily K Sims, Henry T Bahnson, Julius Nyalwidhe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer InterceptionSharia Hernandez, Edwin Roger Parra, Naohiro Uraoka, et al.
Journal of the American College of Surgeons|May 30, 2009
Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?Nipun B Merchant, Jennifer Rymer, Elizabeth A S Koehler, et al.
Gastroenterology|December 17, 2020
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F Fahrmann, C Max Schmidt, Xiangying Mao, et al.
Annals of Surgery|December 31, 2013
A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainageGeorge Van Buren, Mark Bloomston, Steven J Hughes, et al.
Gut|April 23, 2025
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancersYihui Chen, Riccardo Ballarò, Marta Sans, et al.
Pageof 24

Showing results (221-230 of 239) with videos related to

Sort By:
Pageof 24
Annals of Surgery|July 9, 2021
Outcomes in Endoscopic and Operative Transgastric Pancreatic DebridementThomas K Maatman, Sean P McGuire, Katelyn F Flick, et al.
Annals of Surgery|September 3, 2024
Natural History of the Remnant Pancreatic Duct after Pancreatoduodenectomy for Non-Invasive Intraductal Papillary Mucinous Neoplasm: Results from an International ConsortiumRachel C Kim, Giampaolo Perri, Dario M Rocha Castellanos, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alterationMarta Sans, Yihui Chen, Fredrik I Thege, et al.
Diabetes Care|December 12, 2018
Proinsulin Secretion Is a Persistent Feature of Type 1 DiabetesEmily K Sims, Henry T Bahnson, Julius Nyalwidhe, et al.
Diabetes Care|April 24, 2019
Response to Comment on Sims et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258-264Emily K Sims, Henry T Bahnson, Julius Nyalwidhe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer InterceptionSharia Hernandez, Edwin Roger Parra, Naohiro Uraoka, et al.
Journal of the American College of Surgeons|May 30, 2009
Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?Nipun B Merchant, Jennifer Rymer, Elizabeth A S Koehler, et al.
Gastroenterology|December 17, 2020
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F Fahrmann, C Max Schmidt, Xiangying Mao, et al.
Annals of Surgery|December 31, 2013
A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainageGeorge Van Buren, Mark Bloomston, Steven J Hughes, et al.
Gut|April 23, 2025
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancersYihui Chen, Riccardo Ballarò, Marta Sans, et al.
Pageof 24